Cargando…

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands

Novel conformationally restricted analogues of agomelatine were synthesized and pharmacologically evaluated at MT(1) and MT(2) melatoninergic receptors. Replacement of the N-acetyl side chain of agomelatine by oxathiadiazole-2-oxide (compound 3), oxadiazole-5(4H)-one (compound 4), tetrazole (compoun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rami, Marouan, Landagaray, Elodie, Ettaoussi, Mohamed, Boukhalfa, Koussayla, Caignard, Daniel-Henri, Delagrange, Philippe, Berthelot, Pascal, Yous, Saïd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269769/ https://www.ncbi.nlm.nih.gov/pubmed/23262445 http://dx.doi.org/10.3390/molecules18010154

Ejemplares similares

Synthetic Melatoninergic Ligands: Achievements and Prospects
por: Kostiuk, N. V., et al.
Publicado: (2014)

Synthesis and Functional Characterization of Substituted Isoquinolinones as MT(2)-Selective Melatoninergic Ligands
por: Hu, Yueqing, et al.
Publicado: (2014)

Synthesis and Fluorescence Properties of 4-Cyano and 4-Formyl Melatonin as Putative Melatoninergic Ligands
por: Bartolucci, Silvia, et al.
Publicado: (2023)

Local Melatoninergic System as the Protector of Skin Integrity
por: Slominski, Andrzej T., et al.
Publicado: (2014)

(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators
por: Rami, Marouan, et al.
Publicado: (2019)

The Role of the Melatoninergic System in Light-Entrained Behavior of Mice
por: Pfeffer, Martina, et al.
Publicado: (2017)

Temporal expression patterns of the melatoninergic system in the human thymus of children
por: Cruz-Chamorro, Ivan, et al.
Publicado: (2019)

Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus)
por: Gautier, Célia, et al.
Publicado: (2018)

Conformationally Constrained Sialyl Analogues as New Potential Binders of h‐CD22
por: Forgione, Rosa Ester, et al.
Publicado: (2022)

Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
por: Mack, Josiel Mileno, et al.
Publicado: (2016)

New Radioligands for Describing the Molecular Pharmacology of MT(1) and MT(2) Melatonin Receptors
por: Legros, Céline, et al.
Publicado: (2013)

The Role of the Melatoninergic System in Circadian and Seasonal Rhythms—Insights From Different Mouse Strains
por: Pfeffer, Martina, et al.
Publicado: (2022)

Synthesis of constrained analogues of tryptophan
por: Rossi, Elisabetta, et al.
Publicado: (2015)

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
por: Hardeland, Rüdiger
Publicado: (2009)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines
por: Azam, Syed Sikander, et al.
Publicado: (2013)

Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability
por: Said, Mayada, et al.
Publicado: (2017)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Conformally invariant constrained fermion models
por: Cabra, D C, et al.
Publicado: (1990)

Constraining ribosomal RNA conformational space
por: Favaretto, Paola, et al.
Publicado: (2005)

New Quinoxaline Derivatives as Potential MT(1) and MT(2) Receptor Ligands
por: Ancizu, Saioa, et al.
Publicado: (2012)

Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?
por: Moyanova, Slavianka, et al.
Publicado: (2018)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Continuous analogue to iterative optimization for PDE-constrained inverse problems
por: Boiger, R., et al.
Publicado: (2018)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e94on5m1nia8jt5rq07r8uc13m